PTA 週邊 DCB 導管市場：管道報告（發展階段、細分市場、地區/國家、監管途徑、主要參與者），2024 年最新版

PTA Peripheral DCB Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

出版日期: 2024年03月29日 | 出版商:

GlobalData | 英文 106 Pages | 訂單完成後即時交付

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄圖表

PTA 週邊 DCB 導管是一種藥物塗層經皮腔內血管成形術 (PTA) 球囊，旨在預防週邊動脈再狹窄。 PTA 週邊 DCB 導管可向血管壁提供快速、短期、均勻、局部注射，同時保留血管解剖結構，促進血管癒合，並減少長期雙重抗血小板治療的需要，從而提供最佳的藥物輸送。它可用於治療支架內再狹窄（ISR）、分叉、小血管和長病變。

本報告調查了 PTA 週邊 DCB 導管市場，包括產品概述、正在開發的管道產品趨勢、不同開發階段的產品比較分析、正在進行的臨床試驗資訊以及參與公司的最新資訊。

Acotec Scientific Co Ltd
AnGes Inc
AngioCure, Inc.
Ascenion GmbH
Becton Dickinson and Co
Boston Scientific Corp
Cardionovum GmbH
Chansu Vascular Technologies LLC
Concept Medical Inc
Contego Medical LLC
Cordis US Corp
Dingke Medical Technology (Suzhou) Co Ltd
eucatech AG
Lifetech Scientific (Shenzhen) Co Ltd
Lutonix Inc
Medtronic Plc
Micell Technologies Inc
OrbusNeich
Orchestra BioMed Inc
Pulsus Medical LLC
QualiMed Innovative Medizinprodukte GmbH
Shanghai Easy-Flow Medical Tech Co Ltd
Shenzhen Salubris Pharmaceuticals Co Ltd
SiL Vascular Ltd
Spectranetics Corp
Stemplant LLC
SurModics Inc
Tailored Medical Devices Inc
TransMed7 LLC
Vascular Nanotransfer Technologies
Zhejiang Batai Medical Technology Co Ltd
Zylox-Tonbridge Medical Technology Co Ltd

第 6 章 PTA 外周 DCB 導管 - 最新進展

第七章附錄

調查方法
關於環球數據
聯絡我們
免責聲明

簡介目錄圖表

Product Code: GDME1723EPD

GlobalData's Medical Devices sector report, "PTA Peripheral DCB Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the PTA Peripheral DCB Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A PTA Peripheral DCB Catheter is a drug-coated percutaneous transluminal angioplasty (PTA) balloon intended to prevent restenosis, or restenosis of the peripheral arteries. PTA Peripheral DCB catheters provide fast, short-term, homogenous, local drug delivery to the vessel wall, while preserving the anatomy of the vessel, promoting enhanced vessel healing, and reducing the need for prolonged dual antiplatelet therapy. They can be used to treat native and in-stent restenosis (ISR), bifurcations, small vessels, and long lesions.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the PTA Peripheral DCB Catheters under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of PTA Peripheral DCB Catheters and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of PTA Peripheral DCB Catheters under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 PTA Peripheral DCB Catheters Overview

3 Products under Development

3.1 PTA Peripheral DCB Catheters - Pipeline Products by Stage of Development
3.2 PTA Peripheral DCB Catheters - Pipeline Products by Territory
3.3 PTA Peripheral DCB Catheters - Pipeline Products by Regulatory Path
3.4 PTA Peripheral DCB Catheters - Pipeline Products by Estimated Approval Date
3.5 PTA Peripheral DCB Catheters - Ongoing Clinical Trials

4 PTA Peripheral DCB Catheters - Pipeline Products under Development by Companies

4.1 PTA Peripheral DCB Catheters Companies - Pipeline Products by Stage of Development
4.2 PTA Peripheral DCB Catheters - Pipeline Products by Stage of Development

5 PTA Peripheral DCB Catheters Companies and Product Overview

5.1 Acotec Scientific Co Ltd Company Overview
- 5.1.1 Acotec Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.2 AnGes Inc Company Overview
- 5.2.1 AnGes Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 AngioCure, Inc. Company Overview
- 5.3.1 AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.4 Ascenion GmbH Company Overview
- 5.4.1 Ascenion GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.5 Becton Dickinson and Co Company Overview
- 5.5.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
5.6 Boston Scientific Corp Company Overview
- 5.6.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.7 Cardionovum GmbH Company Overview
- 5.7.1 Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.8 Chansu Vascular Technologies LLC Company Overview
- 5.8.1 Chansu Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.9 Concept Medical Inc Company Overview
- 5.9.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 Contego Medical LLC Company Overview
- 5.10.1 Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.11 Cordis US Corp Company Overview
- 5.11.1 Cordis US Corp Pipeline Products & Ongoing Clinical Trials Overview
5.12 Dingke Medical Technology (Suzhou) Co Ltd Company Overview
- 5.12.1 Dingke Medical Technology (Suzhou) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.13 eucatech AG Company Overview
- 5.13.1 eucatech AG Pipeline Products & Ongoing Clinical Trials Overview
5.14 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
- 5.14.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.15 Lutonix Inc Company Overview
- 5.15.1 Lutonix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Medtronic Plc Company Overview
- 5.16.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.17 Micell Technologies Inc Company Overview
- 5.17.1 Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 OrbusNeich Company Overview
- 5.18.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
5.19 Orchestra BioMed Inc Company Overview
- 5.19.1 Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 Pulsus Medical LLC (Inactive) Company Overview
- 5.20.1 Pulsus Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.21 QualiMed Innovative Medizinprodukte GmbH Company Overview
- 5.21.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.22 Shanghai Easy-Flow Medical Tech Co Ltd Company Overview
- 5.22.1 Shanghai Easy-Flow Medical Tech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.23 Shenzhen Salubris Pharmaceuticals Co Ltd Company Overview
- 5.23.1 Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.24 SiL Vascular Ltd Company Overview
- 5.24.1 SiL Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.25 Spectranetics Corp Company Overview
- 5.25.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview
5.26 Stemplant LLC Company Overview
- 5.26.1 Stemplant LLC Pipeline Products & Ongoing Clinical Trials Overview
5.27 SurModics Inc Company Overview
- 5.27.1 SurModics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.28 Tailored Medical Devices Inc Company Overview
- 5.28.1 Tailored Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
5.29 TransMed7 LLC Company Overview
- 5.29.1 TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview
5.30 Vascular Nanotransfer Technologies Company Overview
- 5.30.1 Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview
5.31 Zhejiang Batai Medical Technology Co Ltd Company Overview
- 5.31.1 Zhejiang Batai Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.32 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
- 5.32.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 PTA Peripheral DCB Catheters- Recent Developments

7 Appendix

7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

簡介目錄圖表

List of Tables

PTA Peripheral DCB Catheters - Pipeline Products by Stage of Development
PTA Peripheral DCB Catheters - Pipeline Products by Territory
PTA Peripheral DCB Catheters - Pipeline Products by Regulatory Path
PTA Peripheral DCB Catheters - Pipeline Products by Estimated Approval Date
PTA Peripheral DCB Catheters - Ongoing Clinical Trials
PTA Peripheral DCB Catheters Companies - Pipeline Products by Stage of Development
PTA Peripheral DCB Catheters - Pipeline Products by Stage of Development
Glossary